[由于异常的移植系统分流导致的肝脑病变]
Lærke Vinge Larsen1, Emilie Gt Nissen1, Ruben Juhl Jensen2
1Abdominalcenter K, Københavns Universitetshospital - Bispebjerg Hospital.
Ugeskrift for laeger
|November 28, 2025
概括
肝硬化患者的肝脑病变 (HE) 通过关闭不寻常的骨静脉突变成功治疗. 这种干预程序解决了患者的神经症状,证明了一种新的治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 干预性放射学 干预性放射学
- 神经学 神经学
背景情况:
- 肝脑病 (HE) 是肝脏疾病的一种严重并发症.
- 移植系统的分流可以通过绕过肝脏的排毒功能来加剧HE.
- 不寻常的分流位置带来了独特的诊断和治疗挑战.
研究的目的:
- 报告一种由罕见的端口系统道引起的HE病例.
- 描述了成功的干预治疗这种短道.
- 突出栓塞在解决HE的有效性.
主要方法:
- 一名68岁的男性患者被评估.
- 计算机断层扫描 (CT) 确定了带和股骨静脉之间的大型带系统分流.
- 冲刺被使用干预性皮肤穿栓塞治疗.
主要成果:
- 干预栓塞手术在技术上是成功的.
- 在手术后,患者的肝脏脑病症消失了.
- HE的解决与港口系统的顺利关闭相关联.
结论:
- 大型,不寻常的移植系统分流可以导致或加剧肝脏脑病变.
- 穿皮栓塞是一种有效的治疗方法.
- 干预性放射学为解决与特定分流类型相关的HE提供了最少的侵入性解决方案.
相关概念视频
Hepatic Portal System
5.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
203
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
203
Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Esophageal Varices-I: Introduction
1.1K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.1K
Hepatic Drug Excretion: Enterohepatic Cycling
2.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.6K


